The main problems with initiation and maintenance of insulin therapy, along with solutions to these concerns, are outlined below. Solution: Rapid-acting analogs can be injected within 15 minutes ...

In an awake individual, mild-to-moderate nocturnal hypoglycemia is easily corrected by ingesting a snack containing approximately 5 g of fast-acting carbohydrate ... the basal insulin, a bedtime ...

In 1999, we introduced rapid-acting and, in 2004, long-acting insulin analogues produced by genetic engineering, allowing users to mimic physiological insulin secretion to avoid hypoglycaemia ...

fast-acting insulin analogs, insulin pens using disposable needles and insulin pumps installed with a catheter in the abdomen. Melbourne, Australia-based Phosphagenics has an insulin patch in ...

Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 diabetes as a follow-on drug to Humalog, a rapid-acting insulin that is Lilly’s top selling drug, bringing in almost $700 ...

Objectives: The price of analogue insulin has increased dramatically, making it unaffordable for many patients and insurance carriers. By contrast, human synthetic insulins are available at a ...

Medical innovations have helped in enhancing treatment of neonatal diabetes. Insulin analogs are fast acting and short acting, ideal for use in newborns because they do not take long to affect the ...